4 transcripts
BMY
Earnings call transcript
NYSE
2024 Q2
26 Jul 24
policy. So irrespective of short-term dynamics, we remain very concerned about the long-term implications of IRA on innovation, but we'll be able to give
BMY
Earnings call transcript
NYSE
2024 Q1
25 Apr 24
important drug with significant commercial potential. As we talked about, KarXT will be the first innovative therapy in schizophrenia approved for decades
BMY
Earnings call transcript
NYSE
2023 Q4
2 Feb 24
.
Having said that, we certainly are going to continue to be interested in bringing innovation into the company that makes strategic and financial sense
BMY
Earnings call transcript
NYSE
2023 Q2
27 Jul 23
and growing the business for the long-term centers, first, on our 9 recently launched products. The combination of our scientific innovation
- Prev
- 1
- Next